Palla Pharma Ltd
ASX:PAL
Palla Pharma Ltd
ASX:PAL
Price:
0.295 AUD
Market Closed
Updated:
May 21, 2024
Palla Pharma Ltd
Interest Income Expense
|
Palla Pharma Ltd
Interest Income Expense Peer Comparison
Comparables:
ADO
PIQ
CTE
GSS
E
EZZ
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Palla Pharma Ltd
ASX:PAL
|
Interest Income Expense
-AU$1.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Anteotech Ltd
ASX:ADO
|
Interest Income Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Interest Income Expense
-AU$21.2k
|
CAGR 3-Years
5%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Interest Income Expense
AU$8.7k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genetic Signatures Ltd
ASX:GSS
|
Interest Income Expense
-AU$1k
|
CAGR 3-Years
70%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Interest Income Expense
AU$241.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Palla Pharma Ltd's Interest Income Expense?
Interest Income Expense
-1.4m
AUD
-1.4m
AUD
Based on the financial report for Jun 30, 2021, Palla Pharma Ltd's Interest Income Expense amounts to -1.4m AUD.
What is Palla Pharma Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
0%
0%
Over the last year, the Interest Income Expense growth was 40%. The average annual Interest Income Expense growth rates for Palla Pharma Ltd have been 2% over the past three years .
You don't have any saved screeners yet
